Moody's Investors Service has affirmed Yale-New Haven (Conn.) Health System's "Aa3" rating, affecting approximately $840 million of outstanding debt.
The rating affirmation is based on a number of factors, including YNHHS' leading market position in the state and consistently solid margins.
The outlook is stable, reflecting Moody's Investors Service's expectation that YNHHS will maintain its operating cash flow margins and continue to execute growth strategies.